|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,203.81 MXN | -0.28% |
|
+4.09% | -0.83% |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-25 | Gilead Says FDA Approves Trodelvy for First-Line Treatment of Advanced Triple-Negative Breast Cancer | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GILD Stock
- GILD * Stock
- Charts Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
